Translational Oncology: How to Better Transform Targets into Relevant Drugs for Patients


  • Jeffrey M. Bockman, PhD, VP, Defined Health
  • Mike Rice, MS, MBA, Senior Consultant, Defined Health


  • Joseph Beechem, PhD, SVP, Research and Development, NanoString Technologies
  • Pamela Carroll, PhD, VP, Oncology, Innovation Center in Boston, Janssen Research & Development
  • Rajesh Chopra, MD, PhD, Corporate VP, Translational and Early Drug Development, Celgene Corporation
  • Victoria Richon, PhD, VP and Head of Cancer Research, Discovery and Early Development, Sanofi
  • Spiro G. Rombotis, President & CEO, Cyclacel Pharmaceuticals, Inc.